A critical breakthrough in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in various types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research